PubMed for id: 116173

Year	Number of Results
2002	1
2003	2
2004	2
2007	2
2009	2
2010	4
2011	4
2014	5
2015	2
2016	2
2017	1
2018	2
2019	3
2020	4
2021	3
2022	1
2023	1
2024	0

1

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.

Li L, Hu Y, Chen D, Zhu J, Bao W, Xu X, Chen H, Chen W, Feng R. Li L, et al. Mol Med Rep. 2022 Jan;25(1):17. doi: 10.3892/mmr.2021.12533. Epub 2021 Nov 18. Mol Med Rep. 2022. PMID: 34791506 Free PMC article.

2

[Association between CMTM5 gene and coronary artery disease and the relative mechanism].

Liu TF, Lin T, Ren LH, Li GP, Peng JJ. Liu TF, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1082-1087. doi: 10.19723/j.issn.1671-167X.2020.06.015. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33331317 Free PMC article. Chinese.

3

[Association of CMTM5 gene expression with the risk of in-stent restenosis in patients with coronary artery disease after drug-eluting stent implantation and the effects and mechanisms of CMTM5 on human vascular endothelial cells].

Liu TF, Lin T, Ren LH, Li GP, Peng JJ. Liu TF, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Oct 18;52(5):856-862. doi: 10.19723/j.issn.1671-167X.2020.05.010. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33047719 Free PMC article. Chinese.

4

[Pathophysiologic mechanism of CMTM5 low expression in multiple myeloma progression].

Ma Y, Shi JF, Qiu HY, Yuan J, Zhang Y, Zhou P, Xu JJ, Han QZ. Ma Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):58-62. doi: 10.3760/cma.j.issn.0253-2727.2019.01.011. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 30704230 Free PMC article. Chinese.

5

Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function.

Zhang JW, Liu TF, Chen XH, Liang WY, Feng XR, Wang L, Fu SW, McCaffrey TA, Liu ML. Zhang JW, et al. Gene. 2017 Aug 15;624:56-65. doi: 10.1016/j.gene.2017.04.041. Epub 2017 Apr 28. Gene. 2017. PMID: 28457985

6

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Xiao Y, Yuan Y, Zhang Y, Li J, Liu Z, Zhang X, Sheng Z, Xu T, Wang X. Xiao Y, et al. Clin Transl Oncol. 2015 Jun;17(6):431-7. doi: 10.1007/s12094-014-1253-z. Epub 2014 Nov 12. Clin Transl Oncol. 2015. PMID: 25387568

7

CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.

Zhang H, Nan X, Li X, Chen Y, Zhang J, Sun L, Han W, Li T. Zhang H, et al. Biochem Biophys Res Commun. 2014 May 2;447(2):304-10. doi: 10.1016/j.bbrc.2014.03.158. Epub 2014 Apr 8. Biochem Biophys Res Commun. 2014. PMID: 24721428

8

Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.

Li P, Liu K, Li L, Yang M, Gao W, Feng J, Lv Y, Qu X, Kong B. Li P, et al. Int J Gynecol Cancer. 2011 Oct;21(7):1248-55. doi: 10.1097/IGC.0b013e3182259c31. Int J Gynecol Cancer. 2011. PMID: 21841490

9

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

Niu J, Li H, Zhang Y, Li J, Xie M, Li L, Qin X, Qin Y, Guo X, Jiang Q, Liu Y, Chen S, Huang X, Han W, Ruan G. Niu J, et al. Leuk Res. 2011 Jun;35(6):771-6. doi: 10.1016/j.leukres.2010.11.023. Epub 2010 Dec 18. Leuk Res. 2011. PMID: 21168207

10

[Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma].

Niu JH, Bao L, Zhang Y, Li JL, Li LD, Xie M, Qin YZ, Lai YY, Jiang Q, Shi HL, Liu YR, Jiang B, Chen SS, Huang XJ, Ruan GR. Niu JH, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):363-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20416169 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year